1st Quarter - Report

DUTKO WORLDWIDE, LLC for ABBOTT LABORATORIES

Period 1st Quarter 2008 Filed Apr 3, 2008 Signed by Mark Irion, Chief Executive Officer

Official filing

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
DUTKO WORLDWIDE, LLC
Client
ABBOTT LABORATORIES
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 3, 2008 $60,000 Replaced
1st Quarter - Amendment Apr 9, 2008 $60,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Monitor federal legislation related to Tricare and other health care issues and advise client as it affects them. Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.

LobbyistCovered position, as disclosed
GARY ANDRES —
DARREN WILLCOX —

Contacted: Commerce, Dept of (DOC); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.Con.Res. 312 (110th), H.R. 1908 (110th), H.R. 5629 (110th), H.R. 5501 (110th)

Copyright/Patent/Trademark CPT

Monitor federal legislation related to Patent Reform and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.

LobbyistCovered position, as disclosed
GARY ANDRES —
DARREN WILLCOX —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 5501 (110th), H.Con.Res. 312 (110th), H.R. 5629 (110th), H.R. 1908 (110th)

Health Issues HCR

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.

LobbyistCovered position, as disclosed
GARY ANDRES —
DARREN WILLCOX —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1908 (110th), H.R. 5629 (110th), H.R. 5501 (110th), H.Con.Res. 312 (110th)

Medicare/Medicaid MMM

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Reform Legislation Budge resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization.

LobbyistCovered position, as disclosed
GARY ANDRES —
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); White House Office

Bills named: H.Con.Res. 312 (110th), H.R. 1908 (110th), H.R. 5501 (110th), H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.